Neurological Research and Practice · 2021 · 13 citations · 18 references
Life SciencesImmunologyAutoimmunityImmunizationImmunotherapyB-cell ResponsesCell-mediated ImmunityHumoral ImmunityImmune Response To VaccinationMultiple SclerosisVaccinationControl Group DesignMatched Control GroupOcrelizumab TherapySars-cov-2 InfectionT Cell-mediated Immune ResponseT-cell Mediated Immune ResponseVaccine-induced Antibody ResponsesVaccine-induced T-cell Responses
BACKGROUND: Patients with multiple sclerosis receiving ocrelizumab-treatment are in desperate need of a protection against SARS-CoV-2 infection. METHODS: In this study, Euroimmun semi-quantitative Anti-SARS-CoV-2 IgG for detection of humoral response and ELISpot assays for detection of SARS-CoV-2-specific T-cell-response were used in 10 ocrelizumab-treated patients with multiple sclerosis twice vaccinated with Comirnaty® mRNA vaccine. This data was compared with a control group of 20 age- and sex-matched healthy volunteers, who had all previously received a full SARS-CoV-2 mRNA vaccination with Comirnaty® or Spikevax®. RESULTS: While all subjects in the control group had high humoral response to the vaccination, in B-cell-depleted individuals a significantly reduced antibody response to vaccination against SARS-CoV-2 was observed. SARS-CoV-2 specific T-cell-response, however, did not differ significantly between both cohorts. CONCLUSIONS: T-cell-mediated response to Comirnaty® vaccination is observable despite attenuated humoral response in B-cell-depleted patients. This might enable partial protection against COVID-19. Trial registration Retrospectively registered.
18
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran et al. · Nature · 2020 · 2.2K citations · Full text
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun, Lucie Loyal, Marco Frentsch et al. · Nature · 2020 · 1.4K citations · Full text
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster et al. · Therapeutic Advances in Neurological Disorders · 2021 · 362 citations · Full text